Arsenal Biosciences, Inc.

About Arsenal Biosciences, Inc.

Arsenal Biosciences is a programmable cell therapy company that engineers T cells to treat solid tumors. It integrates high-throughput screening, synthetic biology, machine learning and proprietary manufacturing to create precision gene-edited immune cells designed to overcome the immunosuppressive tumor microenvironment. Founded in 2019 and headquartered in South San Francisco, the company operates a GMP facility and collaborates with academic and pharmaceutical partners to advance next-generation autologous cell therapies into clinical trials for cancers with high unmet need.